CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $49,554 | +1.5% | 72,406 | +77.9% | 0.00% | – |
Q2 2023 | $48,843 | +5.3% | 40,703 | +2.7% | 0.00% | – |
Q1 2023 | $46,390 | +28.3% | 39,650 | -13.1% | 0.00% | – |
Q4 2022 | $36,160 | -17.8% | 45,650 | +24.6% | 0.00% | – |
Q3 2022 | $44,000 | +37.5% | 36,650 | +5.8% | 0.00% | – |
Q2 2022 | $32,000 | -48.4% | 34,650 | 0.0% | 0.00% | – |
Q1 2022 | $62,000 | +17.0% | 34,650 | 0.0% | 0.00% | – |
Q4 2021 | $53,000 | -30.3% | 34,650 | -8.0% | 0.00% | – |
Q3 2021 | $76,000 | -46.1% | 37,650 | -7.0% | 0.00% | – |
Q2 2021 | $141,000 | +7.6% | 40,500 | -45.3% | 0.00% | – |
Q1 2021 | $131,000 | +142.6% | 74,000 | +41.0% | 0.00% | – |
Q4 2020 | $54,000 | +980.0% | 52,500 | +950.0% | 0.00% | – |
Q3 2020 | $5,000 | +400.0% | 5,000 | +400.0% | 0.00% | – |
Q1 2020 | $1,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Inspire Advisors, LLC | 188,796 | $291,000 | 0.08% |
Horst & Graben Wealth Management LLC | 75,722 | $117,000 | 0.03% |
Alpine Global Management, LLC | 83,475 | $129,000 | 0.02% |
Miller Investment Management, LP | 50,000 | $77,000 | 0.01% |
SABBY MANAGEMENT, LLC | 30,863 | $48,000 | 0.01% |
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 49,075 | $76,000 | 0.00% |
Alberta Investment Management Corp | 172,185 | $265,000 | 0.00% |
Syverson Strege & Co | 2,145 | $3,000 | 0.00% |
HighTower Advisors, LLC | 170,623 | $263,000 | 0.00% |
HRT FINANCIAL LP | 90,871 | $139,000 | 0.00% |